Drug extends survival of patients with metastatic colorectal cancer

14 mayo 2015

A drug developed 50 years ago and abandoned because it was considered to be too toxic has gained a second life in an international clinical trial. Research shows the drug and a potentiating agent lengthened the lives of patients with metastatic colorectal cancer, all of whom had exhausted available standard treatments.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/uAbO2ZnNukY/150513211132.htm

Volver